The number of lymph node metastases as a prognostic factor in patients with N1 non-small cell lung cancer.
暂无分享,去创建一个
Cardinale Smith | J. Wisnivesky | Juan P Wisnivesky | Cardinale B. Smith | Sirisha Jonnalagadda | Grace Mhango | G. Mhango | S. Jonnalagadda
[1] M. Roh,et al. Prognostic Significance of Metastatic Lymph Node Ratio in Node-Positive Colon Carcinoma , 2007, Annals of Surgical Oncology.
[2] H. Herr. Superiority of ratio based lymph node staging for bladder cancer. , 2003, The Journal of urology.
[3] C. Belluco,et al. Ratio Between Metastatic and Examined Lymph Nodes Is an Independent Prognostic Factor After D2 Resection for Gastric Cancer: Analysis of a Large European Monoinstitutional Experience , 2003, Annals of Surgical Oncology.
[4] O. Solak,et al. Prognostic significance of surgical-pathologic multiple-station N1 disease in non-small cell carcinoma of the lung. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[5] A. Marchetti,et al. A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer. , 2009, Lung cancer.
[6] H. Li,et al. Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma. , 1999, The Annals of thoracic surgery.
[7] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[8] K. Yasumoto,et al. Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer. , 2004, Lung cancer.
[9] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[10] C. Kang,et al. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer. , 2008, The Annals of thoracic surgery.
[11] Bengt Bergman,et al. Long-term results of the international adjuvant lung cancer trial evaluating adjuvant Cisplatin-based chemotherapy in resected lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] E. Halm,et al. Limited Resection for the Treatment of Patients With Stage IA Lung Cancer , 2010, Annals of surgery.
[13] B. Meyers,et al. Video-assisted thoracic surgery versus open lobectomy for lung cancer: a secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial. , 2010, The Journal of thoracic and cardiovascular surgery.
[14] A. Marra,et al. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis. , 2003, The Journal of thoracic and cardiovascular surgery.
[15] P. Catalano,et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] Kotaro Kameyama,et al. Retrospective study of patients with pathologic N1-stage II non-small cell lung cancer. , 2007, Interactive cardiovascular and thoracic surgery.
[17] V. Rusch,et al. Survival after resection of stage II non-small cell lung cancer. , 1992, The Annals of thoracic surgery.
[18] J. Flickinger,et al. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer , 2009, Cancer.
[19] Bonny R. Hart,et al. Prognostic significance of N1 disease in carcinoma of the lung. , 1983, The Journal of thoracic and cardiovascular surgery.
[20] C. Percy,et al. Accuracy of cancer death certificates and its effect on cancer mortality statistics. , 1981, American journal of public health.
[21] A. Gajra,et al. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] P. Johnstone,et al. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer. , 2005, Chest.
[23] C. Divino,et al. Prognostic significance of the number of lymph node metastases in esophageal cancer. , 2008, Journal of the American College of Surgeons.
[24] Surgical treatment of clinical N1 non-small cell lung cancer: Ongoing controversy over diagnosis and prognosis , 2010, Surgery Today.
[25] C. Mountain,et al. Regional lymph node classification for lung cancer staging. , 1997, Chest.
[26] T. Crabtree,et al. Lymph node evaluation in video-assisted thoracoscopic lobectomy versus lobectomy by thoracotomy. , 2010, The Annals of thoracic surgery.
[27] Tao-Sheng Li,et al. Independent predictive value of the overall number of metastatic N1 and N2 stations in lung cancer. , 2003, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.